Hearing Evaluation of Thalassemic Patients With Desferrioxamine Therapy in Qazvin Thalassemia Center and Tehran Pediatrics & Apos; Medical Center
Objective: The purpose of study was identify hearing loss in thalassemic patients with history of Desferrioxamine (DFO) therapy. This study was carried out in a cross-sectional descriptive survey on 195 thalassemic patients (3-30 years old) in Gazvin Thalassemia center and Tehran pediatrics&apos...
Main Authors: | Shoreh Jalaei, Dr. Ramezan Ali Sharifian, Dr. Ali Reza Karimi Yazdi, Sorayya Nili |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2003-08-01
|
Series: | Audiology |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/6146.pdf&manuscript_id=6146 |
Similar Items
-
The Race for Hydroxamate-Based Zirconium-89 Chelators
by: Irene V. J. Feiner, et al.
Published: (2021-09-01) -
Assessment of the effect of combination therapy with Deferiprone & Desferrioxamine on cardiac complications in major Thalassemia
by: F. Rashidi ghader, M.D, et al.
Published: (2007-01-01) -
Importance of Desferrioxamine Susceptibility in Identification of Staphylococcus epidermidis
by: Gülay KORUKLUOĞLU, et al.
Published: (1997-03-01) -
B- THALASSEMIA MAJOR IN RAMADI
by: Zeina H Al Shemmari, et al.
Published: (2005-07-01) -
NATIONAL THALASSEMIA PREVENTION CAMPAIGN: PROJECT OF TALOTIR
by: Duran Canatan, et al.
Published: (2014-08-01)